Rosuvastatin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Drug-Drug Interaction Study to Estimate the Effect of PF-07081532 on the Pharmacokinetics of Dabigatran and Rosuvastatin in Overweight or Obese Adult Participants
Condition:   Healthy Interventions:   Drug: Dabigatran etexilate (DE);   Drug: Rosuvastatin;   Drug: PF-07081532 Sponsor:   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials

A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin.
Condition:   Dyslipidemia Interventions:   Drug: AZD0780;   Drug: Rosuvastatin Sponsor:   AstraZeneca Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 28, 2023 Category: Research Source Type: clinical trials